Trade Viking Therapeutics, Inc. - VKTX CFD

Trading Conditions

• Type: CFD
• Spread: 0.14
• Long position overnight funding adjustment: -0.02149%
• Short position overnight funding adjustment: -0.00074%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 0.1
• Margin: 50.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 33.91
• Open: 33.5
• 1-Year Change: 11.85%
• Day's Range: 33.11 - 34.16

What is Viking Therapeutics, Inc. (VKTX)?

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders. The company’s research primarily targets conditions such as obesity, non-alcoholic steatohepatitis (NASH), and other metabolic diseases. Viking Therapeutics employs a pipeline approach, advancing multiple drug candidates through various stages of clinical trials. The company’s scientific efforts involve the modulation of specific nuclear hormone receptors and other molecular targets to address underlying disease mechanisms. Viking Therapeutics operates within the biotechnology sector, emphasizing innovation in drug discovery and development. Its organizational structure supports collaborations with academic institutions and research organizations to enhance its therapeutic portfolio. The company’s activities encompass preclinical research, clinical development, and regulatory interactions aimed at bringing new treatments to patients with significant unmet medical needs. Viking Therapeutics is headquartered in the United States and contributes to the broader field of metabolic disease therapeutics through its specialized focus and development programs.

Viking Therapeutics, Inc. Stock Price Today: Live Overview

The price today is shaped by live trading movements, as Viking Therapeutics, Inc. trades around $33.33. Intraday levels have fluctuated between $33.45 and $34.28 with a daily change percentage of -0.4717%.

FAQ: Viking Therapeutics, Inc. (VKTX)

What is the current price of VKTX stock?

The current trading price is $33.33.

Does VKTX pay dividends?

Viking Therapeutics, Inc. does not currently pay dividends.

Does VKTX have a formal corporate presence or regional headquarters in the UAE?

Viking Therapeutics, Inc. has no official regional office or subsidiary in the UAE and operates through partners or distributors.

What is VKTX best known for?

The company is most famous for developing therapies targeting metabolic and endocrine disorders.

What assets are typically shown together with VKTX?

Commonly shown alongside VKTX: Yalla Group Limited, Compugen Ltd., CareDx Inc